N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A1 adenosine receptor

Journal of Medicinal Chemistry

Volumn 43, Issue 2, 2000, Pages 250-260

  Vittori, Sauro ^a   Lorenzen, Anna ^b   Stannek, Christina ^b   Costanzi, Stefano ^a   Volpini, Rosaria ^a   Ijzerman, Adriaan P ^c   Von Frijtag Drabbe Kunzel, Jakobien K ^c   Cristalli, Gloria ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEAZAADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE DERIVATIVE; CYCLOHEXYLADENOSINE; DEOXYADENOSINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; SULFUR 35;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN MEMBRANE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; MEMBRANE BINDING; NONHUMAN; RAT;

ADENOSINE; ANIMALS; BRAIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MAGNETIC RESONANCE SPECTROSCOPY; PHENETHYLAMINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, PURINERGIC P1; TUBERCIDIN; XANTHINES;

EID: 0034719504     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9911231     Document Type: Article

References (36)

1. Stiles, G. L. Adenosine receptor subtypes: new insights from cloning and functional studies. Purinergic approaches in experimental therapeutics; Jacobson, K. A., Jarvis, M. F., Eds.; Wiley-Liss: New York, 1997; pp 29-37.
2. Ralevic, V.; Burnstock, G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50, 413-492.
3. Olah, M. E.; Stiles, G. L. Adenosine receptor subtypes: Characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 581-606.
4. Daly, J. W.; Jacobson, K. A. In Adenosine and adenine nucleotides: from molecular biology to integrative physiology; Belardinelli, L., Pelleg, A., Eds.; Kluwer Academic Publishers: Boston, 1995; pp 157-166.
5. Poulsen, S.-A.; Quinn, R. J. Adenosine receptors: new opportunity for future drugs. Bioorg. Med. Chem. 1998, 6, 619-641.
6. Shryock J. C.; Belardinelli, L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. 1997, 79, 2-10.
7. 1-receptor ligands. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 1994, 267, 55-61.
8. 1 adenosine receptor with receptor/G protein complexes in rat-brain membranes. Mol. Pharmacol. 1996, 49, 915-926.
9. 1 receptor. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 1995, 290, 189-199.
10. 1 receptor in-vivo. Br. J. Pharmacol. 1995, 116, 1957-1964.
11. Van der Wenden, E. M.; von Frijtag Drabbe Künzel, J. K.; Mathôt, R. A. A.; Danhof, M.; IJzerman, A. P.; Soudijn, W. Ribose-modified adenosine-analogues as potential partial agonists for the adenosine receptor. J. Med. Chem. 1995, 38, 4000-4006.
12. 1 receptor in-vivo. J. Pharmacol. Exp. Ther. 1996, 279, 1439-1446.
13. 1 receptors. J. Med. Chem. 1996, 39, 1463-1471.
14. 1 receptors in vivo. J. Pharmacol. Exp. Ther. 1997, 283, 800-808.
15. 1 receptors. Eur. J. Pharmacol. 1997, 334, 299-307.
16. 1 receptor. J. Med. Chem. 1998, 41, 102-108.
17. (a) Cristalli, G.; Grifantini, M.; Vittori, S.; Balduini, W.; Cattabeni, F. Adenosine and 2-chloroadenosine deaza-analogues as adenosine receptor agonists. Nucleoside Nucleotides 1985, 4 (5), 625-639.
18. 6-substituents as adenosine receptor agonists. Nucleosides Nucleotides 1994, 13 (10), 2257-2281.
19. Lupidi, G.; Cristalli, G.; Marmocchi, F.; Riva, F.; Grifantini, M. Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA. J. Enzyme Inhib. 1985, 1, 67-75.
20. Cristalli, G.; Eleuteri, A.; Vittori, S.; Volpini, R.; Camaioni E.; Lupidi, G. Adenosine deaminase inhibitors: Structure - activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues. Drug Dev. Res. 1993, 28 (3), 253-258.
21. Cristalli, G.; Franchetti, P.; Grifantini, M.; Vittori, S.; Klotz, K.-N.; Lohse, M. J. Adenosine receptor agonists: synthesis and biological evaluation of 1-deazaanalogues of adenosine derivatives. J. Med. Chem. 1988, 31, 1179-1183.
22. Gerster, J. F.; Robins, R. K. Purine nucleosides. 8. The synthesis of 2-fluoro- and 2-chloroinosine and certain derived purine nucleosides. J. Org. Chem. 1966, 31, 3258-3262.
23. 6-substituted adenosines. J. Med. Chem. 1973, 16, 358-364.
24. 1-selective adenosine agonists. J. Med. Chem. 1985, 28, 1383-1384.
25. 6-alkyl subregion. J. Med. Chem. 1985, 28, 1636-1643.
26. Kazimierczuk, Z.; Cottam, J. R.; Revankar, G. R.; Robins, R. K. Synthesis of 2′-deoxytubercydin, 2′-deoxyadenosine, and related 2′-deoxynucleosides via a novel direct stereospecific sodium salt glycosilation procedure. J. Am. Chem. Soc. 1984, 106, 6379-6382.
27. 1 receptor. Tetrahedron 1993, 49, 2169-2184.
28. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1988, 337, 687-689.
29. Kazimierczuk, Z.; Vilpo, J. A.; Seela, F. Base-modified nucleosides related to 2-chloro-2′-deoxyadenosine. Helv. Chim. Acta 1992, 75, 2289-2297.
30. Lohse, M. J.; Lenschow, V.; Schwabe, U. Interaction of barbiturates with adenosine receptors in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984, 326, 69-74.
31. 6-(ω-aminoalkyl)-adenosines on adenosine receptor affinity and intrinsic activity. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 1989, 772, 185-193.
32. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 336, 204-210.
33. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 1986, 29, 331-346.
34. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
35. 36S]thio)triphosphate binding. Mol. Pharmacol. 1993, 44, 115-123.
36. De Lean, A.; Hancock, A. A.; Lefkowitz, R. J. Validation and statistical analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 1982, 25, 5-16.